Tuberc Respir Dis > Accepted Articles
DOI: https://doi.org/10.4046/trd.2021.0022    [Accepted]
Published online June 4, 2021.
2020 KSC/KATRD guideline for the diagnosis and treatment of pulmonary hypertension: Executive summary
Jae-Hyeong Park, MD, PhD1  , Jin Oh Na, MD, PhD2  , Jae Seung Lee, MD, PhD3  , Yee Hyung Kim, MD, PhD4  , Hyuk-Jae Chang, MD, PhD5 
1Department of Cardiology in Internal Medicine, Chungnam National University Hospital, Chungnam National University College of Medicine, Daejeon, Korea
2Cardiovascular Center, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Republic of Korea
3Department of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
4Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Kyung Hee University Hospital at Gangdong, Kyung Hee University School of Medicine, Seoul, Korea
5Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Yonsei University Health System, Seoul, South Korea
Correspondence:  Hyuk-Jae Chang,
Email: hjchang@yuhs.ac
Received: 5 February 2021   • Revised: 9 May 2021   • Accepted: 2 June 2021
Abstract
Pulmonary hypertension (PH) is a condition of increased blood pressure in the pulmonary arteries and is diagnosed with increased a mean pulmonary artery pressure ≥25mmHg. It may involve multiple clinical situations. There are five clinical groups according to similar pathophysiological mechanisms, clinical presentation, hemodynamic profiles, and treatment strategies. Although there have been major advances in the management of PH, it is still associated with significant morbidity and mortality. The diagnosis and treatment of PH have mainly been performed following European guidelines in Korea because the country lacks localized PH guidelines. Since foreign treatment guidelines do not reflect regional actual status, diagnosis and treatment have not been tailored well in Korean patients with PH. Thus, we have developed this guideline to facilitate the diagnosis and treat PH appropriately in Korea, where the consensus for diagnosing and treating PH remains insufficient. This is the first edition of the guidelines for the diagnosis and treatment of PH in Korea primarily based on the ‘2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension’ with the acceptance and adaptation of recent publications of PH.
Key Words: Pulmonary hypertension, Treatment, Pulmonary arterial hypertension, Guidelines


ABOUT
ARTICLE & TOPICS
Article category

Browse all articles >

Topics

Browse all articles >

BROWSE ARTICLES
FOR CONTRIBUTORS
Editorial Office
101-605, 58, Banpo-daero, Seocho-gu (Seocho-dong, Seocho Art-Xi), Seoul 06652, Korea
Tel: +82-2-575-3825, +82-2-576-5347    Fax: +82-2-572-6683    E-mail: katrdsubmit@lungkorea.org                

Copyright © 2021 by The Korean Academy of Tuberculosis and Respiratory Diseases. All rights reserved.

Developed in M2PI

Close layer
prev next